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ABSTRACT
Hepatic Nuclear Factor 1 (HNF1, also referred to as
LFB1, HP1 or APF) is a liver-specific transcription factor
required for the expression of many hepatocyte specific
genes. We report here the purification of this rat liver
nuclear protein and the cloning of Its cDNA using a
PCR-derived approach. Seven independent clones
reveal 3 alternative polyadenylation sites and a unique
open reading frame. Both a motif homologous to the
homeodomain and a distal dimerization domain are
required for specific DNA binding. Sequence
comparisons reveal several atypical features at key
positions in the segment corresponding to helices III
and IV of the Antaennapedia homeodomain as well as
a potential 24 amino acid loop in place of the universal
turn between helices II and III. Together with Its
property to dimerlze in the presence or absence of
DNA, these features place HNF1 as the prototype of a
novel subclass of transcription factors distantly related
to homeoproteins.
INTRODUCTION
Transcriptional analysis of the albumin promoter has led to the
identification of the cis-elements (1,2) and the corresponding
transacting factors (3-5) that are required for efficient and
hepatocyte-specific transcription. Mutations in the proximal
element immediately upstream of the TATA motif cause the most
drastic and most hepatocyte-specific effect on transcription (6,
7). The factor interacting with this site has been characterized
in several laboratories (8-11) as binding to proximal control
regions in the promoters of many liver-specific genes as well
as to several of their distal enhancer elements (reviewed in 12,
13). The consensus sequence derived from these binding sites,
g/aGTTAATNATTAACc/a, is palindromic, although it is never
fully symmetrical in its various natural occurences. The HNF1
target site is able to drive tissue-specific transcription of
heterologous, ubiquitous promoters when cloned in both
orientations or even as single or multimerized copies upstream
of a TATA motif (7, 14-16). In the Xenopus laevis albumin
promoter, the HNF1 target site seems to be the only functional
element upstream of the TATA motif (10).
In vitro studies confirm the crucial role of HNF1 in hepatocyte-
specific transcription. Titration of HNF1 protein in rat liver
nuclear extracts using an excess of its specific DNA target
abolishes the transcription driven by liver-specific promoters
containing the HNF1 site (10, 11, 14). Furthermore, highly
purified rat HNF1 protein is sufficient to complement a spleen
nuclear extract for the in vitro transcription of the mouse albumin
promoter (17). We report, here, the isolation of cDNA clones
coding for HNF1 and the preliminary mapping of its DNA-
binding domain which reveals several atypical features.
MATERIALS AND METHODS
Purification and microsequencing of HNF1
The double stranded oligonucleotide PE56a (generated by
annealing the following oligonucleotides : 5' TCGAGTGTGG-
TTAATGATCTACAGTTA-3' and 5'-TCGATAACTGTA-
GATCATTAACCACAC-3'), encompassing the HNF1 binding
site of the rat albumin promoter, was phosphorylated and stepwise
ligated to a Sepharose-bound oligonucleotide bearing a Xhol
cohesive end (18), to generate a specific DNA-affinity
chromatography medium carrying 50-75 /tg DNA/ml gel.
HNF1 purification was monitored by a band-shift assay using
5'-end-labeled PE56a. Liver nuclear extracts were prepared from
150 rats as described (11), except that the second sucrose cushion
was omitted; proteins were resuspended in Elution Buffer (EB:
20% glycerol, 20 mM hepes pH 7.9, O.5 mM EDTA, O.5 mM
DTT, O.5 mM PMSF, 12 mM MgCl2, 1/ig/ml pepstatin,
leupeptin and aprotinin) to a conductivity lower than that of 0.15
mM KG in EB and loaded on five 200 ml columns of heparin
Ultrogel (IBF). HNF1 containing fractions were eluted with 0.35
M KC1, diluted with EB to 0.3 M KC1 supplemented with poly-
dldC (15 /tg/mg protein) and 0.1 % NP40 and loaded on PE56a-
DNA-affinity columns (20 ml total volume). Columns were
washed with 0.3 M KC1 and HNF1 activity was eluted at 0.6
M KC1, with a yield of 20% and a purification factor of 6600
fold, relative to nuclear extracts. 30 ml of pooled fractions
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containing 25—30 /tg of 87—93 kDa HNFl were concentrated
by lyophilisation to 10 ml and dialysed against 10 mM ammonium
acetate containing 0.01% SDS before further concentration to
300 /tl; the protein was electrophoresed on an SDS-10%
polyacrylamide gel (19) and electroblotted onto a polyvinylidene
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Figure 1: Analysis of affinity-punfied HNFl. Dimers stabilized by S-S bonds.
10 ng of labelled PE56a oligonucleotide, in which several thymine residues had
been replaced by bromodeoxyuridine residues, were incubated with 10 /d of
affinity-purified fraction and complexes were resolved by preparative 5% native
PAGE (lane 1); proteins were UV-crosslinked to DNA and two bands (U and
L for upper and lower bands respectively) separately cut and analyzed by 10%
SDS-PAGE in reducing (lanes 2, 3; 0.1% /3-mercaptoethanol) or nonreducing
conditions (lanes 4, 5). The estimated molecular weights of UV-crosslinked
peptides should be reduced by 10-15 kDa, due to the contribution ofthePE-56a
oligonucleotide (11). The fraction corresponding to the peak of DNA-binding
activity was analyzed by silver-stained 8% SDS-PAGE in reducing (lane 7) or
nonreducing conditions (lane 6). m : markers for molecular weights (given in kDa).
difluoride membrane (PVDF); the amidoblack stained 87-93
kd HNFl band was cut out, digested in situ with trypsin and the
eluted tryptic peptides were fractionated by Reversed Phase
HPLC Chromatography followed by gas-phase amino acid
sequence analysis as previously described (20 and references
therein).
Production of a nondegenerate DNA probe using polymerase
chain reaction (PCR)
Enzymatic DNA amplifications with Taq DNA polymerase were
performed in the buffers indicated by Saiki et al. (21) using 10 ng
of oligo-dT primed cDNA from Fao cells (see below) and 1 ng
each of oligonucleotides Cl or C3 and D2 or D4 (see text and
Figure 2). After 50 cycles of primary amplification (one cycle
= 15" at 94°C, 1' at 60°C, 1' at 72°C) a 10% aliquot was futher
amplified for 50 cycles and amplification products were analyzed
on a 20% polyacrylamide gel. DNA of samples displaying only
the expected amplified band (47 bp) in addition to the single-
stranded primers was directly extracted with phenol-chloroform,
phosphorylated, blunt-end ligated to a Bluescribe vector linearized
with Smal and sequenced. A 41-mer oligonucleotidic probe
(CD41, see Figure 2) was derived from the sequence data.
Preparation and screening of cDNA libraries
An amplified X-gtlO cDNA library (oligo-dT primed) from rat
hepatoma Fao cells treated with cycloheximide was prepared
according to standard procedures (22) and was screened with
5'-end-labeled CD41 and A15 probes (Figure 2). Hybridizations
were performed in 6 Xsaline sodium citrate (SSC), 1 xDenhardt's
solution, 50 /ig/ml tRNA, 0.05% sodium pyrophosphate at 42°C;
washes were done at 55 °C in 1 xSSC. Inserts of positive clones
were subcloned in a Bluescribe vector and sequenced on both
strands by the dideoxynucleotide method modified for double-
stranded DNA (23, 24) using successive primers.
Construction of HNFl expression vectors
Full length HNFl cDNA was obtained as follows: the A4 clone
was digested with Sad, treated with T4 DNA-polymerase and
then digested with MM to generate an MluI-SacI HNFl fragment
with a blunt Sad end (nt 200-2240, Figure 4); the 5' part of
HNFl cDNA was synthesized by reverse transcription of rat liver
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Figure 2: HNFl tryptic peptides and PCR derived probe. Sequences of tryptic peptides A, B and CD are given in single letter code, the amino acids encoded by
six codons in CD are underlined. PCR primers used to determine the CD41 sequence are aligned underneath the CD peptide sequence, two of the coding strand
(Cl and C3) on the left and two of the noncoding strand on the right. The nucleotides in the coding strand of the HNFl cDNA clones which matched CD41 are
replaced by dots, those which did not are indicated by their letter code. Oligonucleotide A15 probe was derived from the 5' end of the CD13 clone coding strand;
HNFlhn PCR primer, encompassing the initiation ATG, from the coding strand of the BP14 genomic clone with creation of an anificatial Hindlll site; HNFlm,
encompassing the unique Mlul site, from the noncoding strand of the A4 clone.
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total RNA (10 ng) using a primer complementary to nt 230-250
(Figure 4); the purified cDNA then served as template to generate
a PCR fragment using HNFlhn and HNFlm oligonucleotides
(Figure 2) and the 241 bp fragment thus obtained was digested
at the Hindm and MM sites included in the PCR primers. Both
3' and 5' cDNA fragments were ligated to an Hindm/Hpal
digested pRSV-CAT vector (25), thus generating the pRSV-
HNF1 construct. pRSV-HNFl was digested partially with Ncol
and then with BamHI to obtain a 2369 bp fragment encompassing
the segment 1 -2240 of the HNFl sequence (Figure 4) followed
by the 129 bp Hpal-BamHI segment from pRSV-CAT. This
fragment was cloned between the Ncol and BamHI sites of a (T7
promoter-/9globin leader)-vector, derived from pGEMl (provided
by Dr. R. Treisman), thus putting the whole HNFl coding
sequence in frame with the /Sglobin initiator ATG (pT7/3H
plasmid).
HNFl deletion vectors were constructed as follows: the 774
bp Smal fragment from pT7/SH was cloned in frame with the
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first ATG in an Ncol digested pT7/3H vector repaired with the
Klenow enzyme, thus generating pT7/3H-34/291; pT7/3H-A18/53
was obtained by Xhol digestion of pT7/3H followed by repair
with the Klenow enzyme and auto-ligation; pT7/3H-A34/208 was
constructed by digestion of pT7jSH with Apal, further treatment
with T4 DNA polymerase and auto-ligation.
In vitro transcription and translation
Sense RNA was synthesized in vitro using 10 units of T7-RNA
polymerase (Stratagene transcription kit) and 1 /*g of DNA
templates linearized as follows: the T7j3H-wt, T7/3H-1/390,
T7/3H-1/281 and T7/3H-1/264 transcripts were generated after
digestion of pT7£H with BamHI, Aatll, Ball and AccI
respectively. The T7/3H-34/291, T7/3H-A18/53 and T7/3H-
A34/208 transcripts were obtained after digestion with BamHI
of the corresponding deletion plasmids.
After 1/2 hour incubation at 37°C, phenol/chloroform
extraction and ethanol precipitation, the synthesized RNA was
resuspended in 20 y\ of water and 2 /tl was used for the in vitro
translation with a rabbit reticulocyte lysate system (Amersham).
The reaction mixture (15 y\) included 12 /tl of the cell lysate and
1 id of diluted [35S]L-methionine (<1000 Ci/mmol,
lmmol/ml). The translation was carried out for 1 hour at 30°C,
and quantity and quality of the products were checked by counting
TCA-insoluble 35S and by SDS-PAGE.
Gel retardation assays, SDS-PAGE and UV-crosslinking
experiments
Gel retardation assays and UV-crosslinking experiments with liver
proteins were performed as previously described (11), without
any competitor DNA in the case of affinity-purified fractions.
For each in vitro translated protein, the volume indicated in
the legend for Figure 5A was preincubated for 10 min on ice
with sonicated salmon sperm DNA at a ratio of 0.5 /ig//xl
translation mixture and with competitor oligonucleotide where
mentioned, in 20 y.\ of binding buffer containing 10 mM Hepes,
4mM MgCl2, 0.1 mM EDTA, 4 mM spermidine, 15%
glycerol. After addition of 1 ng of 32P-labelled PE56
oligonucleotide probe, mixtures were further incubated for 10
min on ice and then analyzed by 5 % PAGE in 0.25 x TBE. The
gel was dried and exposed to two sheets of X-ray film with
intensifying screen at -80°C. The film closest to the gel shows
both 35S and 32P signals and the second one only 32P intensified
signals. Figure 5A shows only the pattern of the second film.
SDS-PAGE were done according to Laemmli (19) and, in the
case of in vitro translated protein analysis, treated for
fluorography (22) before exposure.
Figure 3A: Northern blot analysis of HNFl transcripts. 3 /ig of rat liver or spleen
poly A + RNA were fractionated and hybridized with a mixture of full length
HNFl (clone CD26, Figure 3C) and GAPDH probes. Arrows to the left indicate
the estimated size of the different bands. B: Northern blot analysis of alternative
polyadenylation sites usage. In lane b, 12.5 /jg of total RNA from H4II cells
were hybridized with an HNFl antisense RNA probe specific for transcripts of
group HI (see text; Probe HI: nt 3158-3397, Figure 3Q; after the final high
stringency wash, the blot was rehybridized with a full length HNFl cDNA probe
(lane a). C: Schematic map of HNFl cDNA clones presenting three
polyadenylation sites. The extent of each of the seven independent HNFl cDNA
clones is indicated relative to the combined sequence of the HNFl mRNA in
front of the list of the corresponding redundant clones. The HNFl open reading
frame is indicated by a box; tryptic peptides are shown in black. PolyA tails are
indicated by a black box at the end of each clone and the three polyadenylation
sites included in the longest sequence are indicated by triangles. The group III
specific probe (Probe HI) is indicated by a hatched box.
Northern blot analysis
Total RNA from rat liver, spleen or H4H cells was extracted
using the guanidium thiocyanate-CsCl method (26). Poly A +
RNA was isolated by oligo dT cellulose chromatography (22),
electrophoresed through 1.2% agarose-2.2 M formaldehyde gels
and transferred to a Hybond N membrane (Amersham). RNA
markers (0.24-9.5 kb; BRL) were run in parallel and visualized
under UV. cDNA inserts were isolated from agarose gels,
labelled by random priming to a specific activity of 3 —7x 108
cpm//*g for HNFl and 1 X 107cpm//xg for GAPDH and used as
probes. Hybridization was performed at 42°C in 50% formamide,
5 xSSPE, 5 xDenhardt with the 32P-labelled probe for 24 hours.
The membranes were washed at 60°C with 5 XSSC, 0.25% SDS
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Figure 4: HNFl cDNA sequence. Amino acids are given in single letter code above the nucleotide sequence. The numbering adopted, for both the nucleotide and
the amino acid sequences, is initiated at the first codon of the HNFl open reading frame (see text). Underline bold regions indicate tryptic peptides that were sequenced.
• indicates the first nonsense codon.
and 0.1XSSC, 0.25% SDS. Alternatively, an HNFl antisense RESULTS
RNA probe (nt 3158-3397) was prepared by in vitro
transcription with T7 RNA polymerase of a BamHI digested N a t i v e WNFl f o r m s dimeTS ta ^e presence or absence of its
CD 13 clone (Figure 3C). Membranes were hybridized in 50% DNA-target
formamide, 5 x SSC, 5 x Denhardt at 52°C for 16 h. and washed HNFl protein was purified from rat liver in a three step procedure:
at a final stringency of 0.1 x SSC at 74°C for 1 h. preparation of nuclear extracts, chromatography on heparin
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Ultrogel and specific DNA-affinity column as described in
Materials and Methods. The peak of HNF1 DNA-binding activity
produced two complexes in gel retardation assay (Figure 1, lane
1: arrows U and L) and displayed a major 87 — 93 kDa protein,
a 72 kDa polypeptide and several minor polypeptides (Figure
1, lane 7). To determine which of these polypeptides directly
interacted with DNA, we performed UV-crosslinking
experiments, in which 32P-labelled oligonucleotide containing
BrdU residues was covalently linked to the proteins in the
retardation gel, before the upper and lower band were excised
and run on a SDS-polyacrylamide gel. The upper complex gave
rise to a roughly 100 kDa band corresponding to the 87-93 kDa
protein linked to the 15 kDa oligonucleotide, which is in
agreement with the molucular weight previously reported for
HNF1 (27, 11, 12, 17). The heterogeneity of the 87-93 kDa
band (lane 7) is probably caused by the glycosylation of HNF1
(see below). The lower complex gave rise to the same 100 kDa
band in addition to faster migrating species, likely to be
proteolyzed chains since the yield of this lower retarded band
increased during the purification procedure. The fact that the
HNF1 binding site was almost palindromic suggested a hypothesis
in which the upper complex would contain two intact 87—93 kDa
polypeptide chains and the lower band one intact and one partially
degraded chains; the profile obtained in lanes 2 and 3 is
compatible with this hypothesis. Analysis of the UV-crosslinked
DNA-protein complexes in nonreducing conditions gave slower
migrating bands, suggesting that HNF1 might either associate
with another polypeptide chain or form dimers covalently linked
by S-S bonds (Figure 1, lanes 4 and 5). This interaction appeared
to be specific since the same patterns were observed whether
crude liver nuclear extracts or various purified fractions were
used (data not shown). Further support for potential dimerization
came from the observation that a major fraction of the 87—93
kDa HNF1 band ran as a 180 kDa species under nonreducing
conditions (Figure 1, lane 6). In addition, this suggested that the
protein might preexist as a dimer in the absence of DNA ; neither
addition of specific or unrelated DNA nor irradiation with UV-
light increased the yield of dimerization observed in lane 6 (not
shown). These observations were further strengthened using
cloned HNF1 (see below). Gel retardation assays performed in
the presence of different reducing agents, indicated that S-S bond
formation was not required for DNA-binding in vitro (data not
shown), nevertheless, the factor might still need to dimerize for
this purpose.
In order to obtain protein sequence data for the 87-93 kDa
chain, 150 pmoles were further purified by SDS-PAGE, since
no other polypeptide was visible on two-dimensional gels at the
same molecular weight level (not shown), then transferred to a
PVDF membrane and digested in situ with trypsin. The tryptic
peptides were fractionated on reversed phase HPLC and
submitted to amino acid sequence analysis. The three sequences
obtained are listed in Figure 2. Peptides A and B were used to
derive redundant oligonucleotides for direct screening of cDNA
libraries from rat liver or hepatoma cell lines. After several
unsuccessful attempts, we turned to a PCR-derived approach to
get better probes for HNF1.
Use of PCR to generate a unique probe for HNF1
From the longest peptide (CD), four degenerate primers, two
of the coding strand (C1 and C3) and two of the noncoding strand
(D2 and D4), were designed to reduce the high degeneracy due
to serine and leucine residues (see Figure 2). These
oligonucleotides were used in an enzymatic amplification on Fao
cells cDNA, followed by cloning and sequencing of the expected
47 bp PCR-amplified fragment. The nucleotides coding for the
alanine and the two central serine residues of the CD peptide
were thus unambiguously determined and a 41-mer
nondegenerated probe was synthesized according to this sequence
data (CD41 in Figure 2).
Since the C and D primers were highly degenerate (respectively
512 and 1024 mixed sequences) and PCR is a primer-limiting
procedure, only about 1 % of the 47 bp amplified fragments that
were visible on a gel might display the exact HNF1 sequence.
The remaining must contain some mismatches mainly in the ends
of the fragments, since elongation by Taq-DNA-polymerase
requires a better annealing at the 3' end of the primers. The
nucleotides that were actually wrong in the single PCR fragment
that we sequenced as compared to the final cDNA sequence are
indicated in Figure 2.
Seven independent HNF1 cDNA clones display three
polyadenylation sites and a single open reading frame
With the CD41 probe, we screened 106 clones of a X-gtlO
cDNA library prepared from rat hepatoma Fao cells (28), treated
with cycloheximide to increase the representation of potentially
unstable transcripts (29). We first isolated 3 partial cDNA clones
(CD13, CD16, CD39); one of them (CD13) included the two
others. A 45 bp probe (A15, Figure 2) from the most 5' region
of this clone was synthesized and used to screen the same library.
Seven new clones (A-clones and CD26) were isolated that were
also positive with CD41. The structure of the ten clones including
three pairs of identical ones is described schematically in
Figure 3C.
The total length of the combined nucleotide sequence (CD26
and the 3' end of CD39 without the oligoA tail) was 3205 bases.
The cDNA clones could be ordered in three groups (I, n, III,
see figure 3C) according to the position of their polyA tails
relative to the combined sequence. When these clones were used
to probe Northern blots with rat liver polyA RNA, a minor and
a major species of 3.2 and 3.6 kb respectively were detected
(figure 3A). Hence, our longest clone could not cover the entire
length of the 3.6 kb mRNA and was probably missing a few
hundred base pairs.
In addition, using a probe derived from the most 3' sequence
of clones of the group ID, only the 3.6 kb species was detected,
thus demonstrating that more than one polyadenylation site were
actually used in vivo (Figure 3B). Examination of the sequences
upstream of the polyA tails found in the three groups of clones
revealed three possible alternative polyadenylation signals. The
four independent clones of group I utilize the AGTAAA sequence
at position 2864 (numbering of the figure 4, see below) with a
polyA chain 14 to 16 nt downstream; the single clone of group
II might use the AATGAG sequence at position 3027 with a
polyA chain 17 nt downstream; finally, the two clones of group
EU utilize the AATAAA sequence at position 3361 with a polyA
chain 31 nt downstream (30). The Northern blot analysis
suggested that, in rat liver, the most 3' site is used predominantly
in rat liver. The situation was different in rat hepatoma cell lines
(S.C., unpublished observations).
Conceptual translation of the cDNA sequence revealed a single
open reading frame of 564 triplets, followed by a long
nontranslated region. The open reading frame included peptides
A, B and CD (underlined in figure 4) as well as two additional
peptides that were not separated by the HPLC and gave short
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Figure 5: Functional mapping of the HNF1 protein. A: In vitro translated HNF1 analyzed by Band-shift assay. 1 ng of 32P-labelled PE56a probe was incubated
as described in Materials and Methods with 1 jig of rat liver nuclear proteins (lanes 4, 12) or with in vitro products of following constructions, in absence (lanes
1 — 11 and 17—22) or presence of 9 ng of unlabelled PE56a as competitor (lanes 12-16); the respective volumes of translation mixture used in binding assay and
lanes in the Figure are indicated in paranthesis: no proteins (lane 1); reticulocyte lysate incubated without exogenous RNA (1 jil, lane 2); antisens HNF1 RNA (1
li\, lane 3); T7/3H-wt (1 pi, lanes 5, 13); T7/3H-1/390 (1 »U, lanes 6, 14); T7/3H-1/281 (1 yi, lanes 7, 15); T70H-1/264 (1 pi, lane 8); T7/3H-34/291 (3 pi, lanes
9, 16); T7/3H-A18/53 (3 /J, lane 10); T70H-A34/2O8 (3 /J, lane 11); co-translation of approximately 1 tag of both mRNA from T7|3H-wt and T7/3H-1/390 (1 /J,
lane 17), T7/3H-1/281 (1 /J, lane 18), T70H-1/264 (1 pA, lane 19), T70H-34/291 (1 pi, lane 20), T70H-A18/53 (1 ^1, lane 21) or T7/3H-A34/208 (1 y\, lane 22).
Band-shift assay were performed as described in Materials and Methods. Note that the band visible in lane 2 is common to all lanes where in vitro translated proteins
were used and is due to a reticulocyte DNA-binding activity. Arrows to the left of lane 17 indicate the positions, from top to bottom, of wilt type homodimers,
heterodimers and T70H1/39O homodimers. B: In vitro translated HNF1 analyzed by SDS-PAGE. 2 ft\ of translation mixtures were diluted with 8 jd of water, left
I hour at room temperature, mixed with 10 /J of Laemmli's sample buffer (19) in presence (lanes 1 -14) or absence (lanes 15-28) of 0.1 % 0-mercaptoethanol
and separated on two identical SDS-8%-polyacrylamide gels that were subsequently autoradiographed for 35S-mel-labelled protein detection. In the translation or
co-translation reactions, approximately 1 fig of mRNA from each of the following constructions were used and the respective lanes on gels are indicated in paranthesis:
T7/3H-wt (lanes 1, 15); T70H-1/39O (lanes 2, 16); T7/3H-1/281 (lanes 3, 17); T70H-1/264 (lanes 4, 18); T7/3H-34/291 (lanes 5, 19); T7/3H-A18/53 (lanes 6, 20);
T70H-A34/2O8 (lanes 7, 21); T70H-wt and T7/3H-1/39O (lanes 9,23), T7/3H-1/281 (lanes 10, 24), T7/3H-1/264 (lanes 11, 25), T70H-34/291 (lanes 12, 26), T7/3H-
A18/53 (lanes 13, 27) or T7/3H-A34/208 (lanes 14, 28). 14C -labelled molecular weight markers (92.5, 69, 46 and 27 kDa; Amersham) were loaded in lanes 8
and 22. Dots on the left of bands on the autoradiogram indicate the homo- or hetero-dimers. Since an excess of intact protein was used in lanes 9—11 and 23 — 25,
we do not detect homodimers of truncated proteins in these experiments.
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mixed sequences; all were preceded by arginine or lysine residues
as expected for tryptic peptides. The first methionine in this open
reading frame was in the 54th position (amino acid no. 118 in
Figure 4), thus generating a polypeptide of 511 amino acids with
a molecular weight of 54.7 kDa, probably too short when
compared with the 87-93 kDa protein that we purified. The
absence of the initiation ATG in the cDNA clones was confirmed
by analysis of a genomic clone (BP14) obtained by screening
a rat library with a cDNA probe. The sequence of this clone
partially overlapped the 5' sequence of the cDNA clones. The
first ATG codon preceded by a nonsense codon in phase was
located 192 nucleotides upstream of our cDNA 5' end (I.B.,
unpublished results). Using a PCR primer overlapping this
putative initiation codon and a second primer encompassing a
unique Mlul restriction site in our cDNA sequence (respectively
HNFlhn, and HNFlm in Figure 2), we amplified a 241 bp
fragment from a rat liver cDNA preparation, thus making sure
that there was no splicing event within the first 192 coding base
pairs. This was confirmed by cloning and sequencing of the PCR
fragment. This sequence, combined with that of the cDNA clones,
gives rise to an open reading frame encoding a polypeptide of
628 amino acids with a calculated molecular weight of 69 kDa
(see Figure 4). This sequence is virtually identical to recently
published cDNA sequence for the LFB1 rat liver factor that was
purified as a 45 kDa protein : the exceptions are 1 nt in the codon
no. 434, coding for a valine in both sequences, and 7 nt in the
noncoding region (31). A partial cDNA sequence of rat HNF1
was recently published by another group (32).
In vitro translated HNF1 requires a motif homologous to the
putative recognition helix of the homeodomain for specific
DNA-binding
To confirm that the cDNA we obtained coded for a protein that
could indeed bind specifically to the albumin proximal element,
we inserted its complete coding sequence in a pGEMl derived
vector and synthesized HNF1 by in vitro transcription and
translation. The 35S-met-labelled protein was analyzed by both
a gel retardation assay and SDS polyacrylamide electrophoresis.
When incubated with its specific DNA-binding site as probe
(PE56a), in vitro translated HNF1 gave rise to a complex that
was specifically displaced by the homologous oligonucleotide (see
lanes 5 and 13 in Figure 5A) but not by a mutated HNF1 DNA
target (DS34 (11); not shown), thus demonstrating that our cDNA
clone actually encoded the activity that had been purified from
rat liver. In vitro translated HNF1 had an apparent molecular
weight of 80 kDa, lower than that observed for the purified rat
liver protein (87-93 kDa; Figure 1, lane 7, Figure 5A, lanes
4 and 5 and 5B) and these variations are likely to be due to the
glycosylation of HNF1 (17 and our unpublished data).
Examination of the complete amino acid sequence of HNF1
(Figure 4) reveals essentially two domains separated by a flexible
junction rich in prolines and glycines (residues 288 to 297). The
amino acid composition of the two domains is clearly different
suggesting that they could have evolved separately. General
features of the HNF1 protein primary sequence are schematically
represented in figure 6A.
The sequence VYNWFANR (residues V264 to R271) of
peptide A matches the consensus sequence I/V-WF-NRR highly
conserved in the putative DNA-recognition helix of
homeodomains (36). Comparison of the HNF1 sequence and
homeoboxes identified to date is discussed below. To check
whether this homology was functionally relevant, we analyzed
the effect of progressive C-terminal deletions on HNF1 DNA-
binding. Figure 5A shows that HNF1 can still bind DNA
specifically when the whole C-terminal domain has been deleted
(deletions T7/3H-1/390, T7/3H-1/281; Figure 5A, lanes 6 and 7
resp.) but not when further deletion removes a short segment
containing the putative recognition helix (deletion T7/3H-1/264;
Figure 5A, lane 8). Thus, the C-terminal end of the HNF1 DNA-
binding domain is localized within the 17 amino acids 265 to 281.
The HNF1 homeodomain is unable to bind specifically to its
DNA target in the absence of a distal dimerization domain
In order to map the N-terminal end of the HNF1 DNA-binding
domain, we constructed deletions using different restriction sites.
The N-terminal domain encoded by the longest Smal fragment
of the HNF1 cDNA, in which the first 33 amino acids are
removed and 59 extra amino acids encoded in the second phase
are added in C-terminal, retained only 1 —2% of the wild type
activity (deletion T70H-34/291; Figure 5A, lane 9). Deletion of
35 amino acids from E18 to T53 encoded by the single Xhol
fragment of the HNF1 cDNA led to a complete loss of specific
DNA-binding (deletion T7/3H-A18/53; Figure 5A, lane 10). This
deletion mutant could bind the PE56 probe with very low
efficiency but only in the absence of any competitor DNA (not
shown). Finally, the deletion of 175 amino acids from G34 to
P208, encoded by the unique Apal fragment of the HNF1
sequence, abolished specific as well as nonspecific DNA-binding
activity (deletion T7/3H-A34/208; Figure 5A, lane 11 and data
not shown).
Thus, the HNF1 homeodomain appeared to be unable to stably
bind DNA by itself and the question arose as to whether it would
need to dimerize to do so, since dimers of native HNF1 had been
observed as discussed above. This prompted us to analyse, by
band-shift assay, the ability of the different deletion mutants to
form DNA-bound heterodimers with the co-translated wild type
protein. In addition, in order to analyse dimerization
independantly of DNA binding, we ran the same mutants on SDS-
polyacrylamide gels in nonreducing conditions, thus taking
advantage of the potential spontaneous S-S bond formation
between two HNF1 monomers.
The first two C-terminal deletion mutants presented, on
nonreducing SDS gels, the variations in mobility that were
expected for truncated HNF1 homodimers (Figure 5B, lanes
15 -17), thus confirming the observations made with the native
protein. Co-translation of wild-type HNF1 with those mutants
revealed heterodimers by both techniques (Figure 5A, lanes 17
and 18 and 5B, lanes 23, 24). As mentioned above, deletion of
the putative recognition helix abolished DNA binding, thus
making it impossible to check by band-shift analysis whether or
not the resulting mutant could dimerize. In fact, it could still form
homodimers and more clearly heterodimers which were
visualized on a SDS-polyacrylamide gel (Figure 5B: lanes 18 and
25). Thus, it appeared that amino acids C-terminal to the V264
were not required for HNF1 dimerization.
In contrast, the three deletions in the N-terminal domain
strongly reduced or abolished both DNA-binding and
dimerization, although in different manners. First, as mentioned
above, the T7/3H-A18/53 deletion mutant lost the ability to bind
specifically to the HNF1 DNA target site; it also failed to form
heterodimers with the intact protein in both the DNA binding
assay and SDS PAGE in nonreducing conditions (figure 5A, lanes
10 and 21; figure 5B, lanes 20 and 27). It should be noted
however, that the deletion of C50 makes the method irrelevant
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given by the amino acid numbers used in the Figure 4. Motifs that might be involved in transactivation and nuclear transport (according to 33 and 34 resp) correspond
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three helices and the 24 amino acid loop present in the HNFl with a loop model of homeobox are also represented (see text and Figure 7). B: Deletion analysis
of the HNFl DNA binding domain. The 7 constructions described in text are schematically represented with same scale as in Figure 6A. Parts of the HNFl with
a loop homeodomain that are present in each of them are also represented. A hatched box indicates the 59 extra amino acids, encoded in the second phase, that
are C-terminal in the T7/3H-34/291 protein. N and C indicate the terminal parts of the wild type HNFl protein when present in the deletion mutants. Results of
Figure 5 are summarized in the right part of the Figure.
for this mutant without precise identification of the cysteine
residues involved in S-S bond formation. In any case, these results
demonstrated that the homeodomain is not sufficient for specific
DNA binding and indicated that formation of the HNFl dimers
requires sequences far from the homeodomain. Second, the
residual DNA binding activity observed with T7/3H-34/291
suggested that the N-terminal part of the HNFl dimerization
domain (upstream of G34) is still required but perhaps less crucial
than the rest of it (which includes some amino acids from G34
to T53). Indeed, the fact that DNA binding is completely lost
by T7/3H-A18/53 and that the T7/3H-34/291- and
T7/3H-1/281 -DNA complexes have similar electrophoretic
mobilities makes unlikely, though does not exclude, the
hypothesis of a monomeric interaction of the HNFl-34/291
molecule with DNA and rather suggests a weak residual ability
to dimerize for this mutant. Nevertheless, this mutant did not
form heterodimers when co-translated with wild type HNFl and
dimers including it have not yet been detected in nonreducing
protein gels (Figure 5A, lane 20 and 5B lanes 19 and 26). It is
possible that it dimerizes poorly in the absence of DNA and
cannot compete for the dimerization process with the wild type
protein, when co-translated. Finally, the third N-terminal deletion
T7/3H-A34/208, which was also unable to dimerize, confirmed
that there are some amino acids crucial for dimerization
downstream of P33 (Figure 5B, lanes 21, 28). In addition, it had
lost any affinity for any type of DNA which, we assume, was
retained by T7/3H-A18/53 thanks to an intact homeodomain
moiety. This suggested that the N-terminus of the HNFl
homeodomain could lie upstream of A209 (see also discussion
below).
DISCUSSION
The HNFl DNA-recognition domain is probably not a
classical helix-turn-helix motif
To document the homology between the DNA-recognition
domain defined above and the homeodomain, we aligned the
predicted amino acid sequence of HNFl in the region of peptide
A with 87 of the 60 amino acid-long homeobox motifs compiled
to date (37, 38). The mean overall homology was approximately
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Figure 7: HNF1 homeodomain compared to the homeodomains sequenced to date. The HNF1 with a 3 amino acid turn (residues R220 to H279) and the HNF1
with a 24 amino acid loop (residues G199 to H279) sequences were aligned separately with the 31 positions where a consensus could be found among more than
60% of the homeoprotein (hom-cons, 37). Amino acids are single letter coded and 5 additional codes are used for the hom-cons sequence as follows: B= Big hydrophobic
i.e. F, Y or I; J = I or L; O = T or S; U = V or I; X = K or R; Z = P or L. A diagram below each sequence illustrates the agreement with the consensus
as follows: each of the 31 positions conserved in the homeobox consensus sequence is represented by a small or a big bar when between 60 to 80% or more than
80% of the homeoproteins agree with the consensus respectively. The bar is black when the corresponding HNF1 amino acid is in structural agreement with the
consensus and pale when it differs. A star (*) indicates an atypical feature specific to HNF1 (see text). Boxes at the bottom indicate the location of helices identified
by three-dimensional NMR in the Antp homeodomain (40) and by X-ray crystallography in the X-Cro helix-tum-helix motif (41). h letters indicate the a-helical
segments predicted from the HNF1 sequences and from the Antp homeobox sequence as a control, according to the algorithm of J. Gamier et al. (35). Numbers
below the hom-cons. sequence indicate positions in the canonical homeobox sequence (18). Numbers below the HNF1 sequences indicate positions of their ends
in the complete HNF1 amino acid sequence (Figure 4).
17%, clearly concentrated in the third helix. As recently proposed
by Finney (39), allowing the looping out of 24 amino acids
('HNF1 with a loop') in the place of the canonical 3 amino acid
turn ('HNF1 with a turn') between helices II and III in the HNF1
sequence led to significant improvement in homology (mean:
23%).
Figure 7 illustrates the degree of structural homology between
the HNF1 sequence, in both configurations discussed here, with
the consensus for the homeodomain (see criteria adopted in
legend). The homology is clearly restricted to the third helix in
the case of HNF1 with a turn and extends largely to the whole
N-terminal region in the case of HNF1 with a loop. Moreover,
predicted a-helices, using the algorithm that gave the best result
with the Antp sequence, as compared to available structural data
(40), perfectly match those of the Antp homeodomain in the case
of HNF1 with a loop while they are hardly compatible in the
case of HNF1 with a turn.
If further structural analysis were to confirm the validity of
the HNF1 with a loop model, one might wonder about the exact
nature of the selective pressure that led to an almost universal
conservation of a strict 3 amino acid turn among the helix-turn-
helix proteins and about the properties of the loop that allowed
HNF1 to escape this selection.
Proteins of a new family, including two that are mammalian
transcription factors restricted to a specific cell type, share a
highly homologous homeobox and two sequences upstream of
it, defined as 'POU-A' and 'POU-B' (see references 38, 42 and
43 for review). The two latter show some homology with the
HNF1 sequence, however it is very weak (highest scores : 6/26
and 4/34 respectively) as compared to homologies between the
already described POU proteins themselves (42, 38). Moreover,
these sequences overlap the HNF1 homeodomain whereas they
are separated by roughly 20-30 amino acids in POU proteins
(42, 38).
Further careful examination shows that several amino acids
of the segment corresponding to the putative DNA-recognition
helix in the HNF1 sequence differ radically in their nature from
those found in most if not all other homeobox sequences (37).
These positions are outlined as stars (*) in Figure 7. Let us retain
two features that are exclusive to HNF1: An alanine at position
50 : the residue in this position is believed to determine the
specificity of DNA-recognition of homeoboxes of the Antp
subclass (44, 45). At this key position most known homeoboxes
contain a glutamine (the other residues that have been found until
now are K, C, S, H, I). An aliphatic residue at this location may
seriously impair binding to DNA through hydrogen bonding or
polar interactions which might explain why HNF1 should bind
to DNA as a dimer. A glutamic acid and an alanine at positions
55 and 57 respectively: all known homeoproteins have an arginine
or a lysine at these extremely conserved functional positions and
almost all at the adjacent position 58 also. The replacement,
exclusive to HNF1, of these three basic residues by one acidic
and two hydrophobic ones is striking, since these amino acids
have been recently demonstrated to be exposed on the external
face of the fourth helical segment of the Antp homeodomain and
proposed to be involved in general electrostatic contacts with
DNA (40); they are usually taken as a distinctive character of
all homeoproteins (43). More precise mutagenesis is needed to
define which amino acids in the long third helix of HNF1 are
involved in contacting DNA, since they are likely to differ from
those of both the canonical homeodomain and prokaryotic helix-
tum-helix motif, possibly in relation to the presence of the 24
amino acid loop.
The HNF1 DNA-binding domain includes a distal
dimerization domain of new type
The similarities and differences between HNF1 and other
homeoproteins prompted us to compare the HNF1 target site to
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other homeoprotein binding sequences determined to date.
Homeoprotein DNA binding sites are AT-rich and similar to the
average consensus sequence for one half of the HNF1 palindromic
binding site (not shown). However, two points should be
mentioned: first, except in yeast, homeoprotein target sites
identified so far lack dyad symmetry; second, the HNF1
monomer has never been shown to form a stable complex with
DNA. Rather, taken together, the different experiments reported
here, using both native and cloned HNF1, strongly suggest that
HNF1 forms homodimers, in the absence of DNA as well as
when bound to its DNA target and that dimerization is essential
for specific and high affinity DNA-binding. A domain required
for dimerization lies outside of the homeodomain in a distal N-
terminal region of the HNF1 protein. This region is rich in
predicted a-helical structures and shows remote homologies with
sequences involved in coiled coil formation but is not included
in any existing dimerization motif family (not shown). During
revision of our manuscript, anoter group outlined the crucial role
of the N-terminal segment of HNF1 for dimerization and DNA-
binding (48) An N-terminal dimerization domain was also
observed in the Mat-a2 homeoprotein (46) to which it confers
a very interesting flexibility in its interactions both with DNA
and with other proteins (46, 47). Mat-a2 dimers are like here
stabilized in vitro in nonreducing conditions, the physiological
relevance of which is unknown. The need to dimerize for DNA-
binding has so far been observed with no other homeoprotein.
By contrast, this property is shared by most of the prokaryotic
factors of the X-Cro-type (41).
HNF1 properties extend the field of the homeoprotein
superfamily
The example of HNF1, in addition to that of the POU proteins,
further documents the homeodomain as the DNA recognition
moiety of transcription factors implicated in the control of cell
specific genes (43). As we discussed before, several predicted
structural features extend the properties encountered among
homeoproteins; this is also true at the functional level. HNF1
was initially identified only in hepatic nuclear extracts (8-11),
however, northern blot and in situ hybridization showed that
HNF1 transcripts are present at high levels in nonhepatic tissues
like intestine and kidney (32 and our unpublished observations).
On the other hand, expression of exogenous HNP1 is not
sufficient to drive a high rate of transcription of a co-transfected
albumin promoter in several cell types (F. Tranche, unpublished
results). Thus, achievement of tissue specific patterns of
transcription does not appear to be based on the action of strictly
tissue specific trans-acting factors, but rather on various
combinations of a small number of proteins. Homeoproteins, like
HNF1, might fulfill complex regulation networks by alternative
homo- or hetero-dimerizations and the low specificity observed
in DNA recognition by the homeoproteins might be overcome
by specific protein-protein interactions.
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